Onco-Innovations amends private placement pricing to $0.65 per unit

Onco-Innovations Limited (CBOE CA: ONCO) announced it has amended the pricing of its previously announced non-brokered private placement. The company now intends to issue up to 3,076,923 units at $0.65 per unit, targeting aggregate gross proceeds of up to $2 million.

Each unit consists of one common share and one share purchase warrant. The warrants are exercisable at $0.75 per share for three years. The company also plans to issue shares equal to 1% of the total shares issued as administrative fees to a third party.

Onco-Innovations may pay finders' fees or issue finders' warrants to parties who introduce subscribers to the placement. The closing remains subject to regulatory and other approvals.

All securities issued will be subject to a four-month and one-day hold period under applicable securities laws. The company stated it intends to use proceeds for general corporate and working capital purposes, including operational and research and development objectives and investor relations.

The Vancouver-based company operates in cancer research and treatment, holding an exclusive worldwide license to patented technology targeting solid tumors. The original private placement was announced January 23, 2026, according to the company's press release.

Onco-Innovations trades on multiple exchanges including CBOE CA under ticker ONCO, Frankfurt as W1H, and OTCQB as ONNVF.

You May Also Be Interested In

• Trifecta Gold closes $1.66M private placement for Yukon exploration
• VivoPower shifts focus to AI data centers, revises unit spinoff plans
• Crusoe in talks to raise $3B in funding - Bloomberg